← All decks

General Surgery

Perspective on Malignant Esophageal Disease (A)

Built from Maingot's Abdominal Operations

The first 25 slides of Perspective on Malignant Esophageal Disease (A)
The first 25 slides, exactly as they appear. The full deck has 84 content slides.

What’s inside

14 sections · 84 slides

  1. 01

    About this perspective

    A senior esophageal surgeon comments on three reviews, and says where he would do things differently

    • Purpose and scope of this perspective
    • Themes running through the commentary

    2 slides

  2. 02

    The rise of esophageal adenocarcinoma

    The largest epidemiologic change ever recorded for a solid cancer, and a hypothesis about what drives it

    • Scale and pattern of the rise
    • Reflux of stomach contents into the esophagus
    • The acid-suppression hypothesis
    • Symptom relief on medication and cancer odds
    • How a higher gastric pH lets bile acids act
    • From acid suppression to adenocarcinoma
    • Why severe persisting symptoms may carry less risk
    • Squamous, intestinalized and gastric linings meeting in one field
    • Goblet cells in intestinalized columnar lining

    9 slides

  3. 03

    Surveillance in Barrett's esophagus

    Taking issue with the dogma that watching a Barrett segment does not save lives

    • Surveillance and survival: the current dogma
    • Stage at detection in their own series
    • Surveillance biopsies in the lower esophagus

    3 slides

  4. 04

    Defining the gastroesophageal junction

    A boundary nobody can agree on, and the effect that has on counting cancers

    • Cardia cancers in the new staging system
    • Where the esophagus meets the stomach
    • The 2000 anatomic definition and its limits
    • A histologic definition of the junction
    • Types of metaplastic columnar lining
    • Consequences of counting the junction correctly

    6 slides

  5. 05

    High-grade dysplasia and endoscopic therapy

    How far endoscopy can go before the esophagus has to come out

    • High-grade dysplasia as the threshold for treatment
    • Endoscopic mucosal ablation versus esophagectomy
    • Visible lesions inside a flat Barrett segment
    • Depth of invasion decides the treatment
    • Depth of tumour invasion through the esophageal wall
    • The wall layers that matter for this decision
    • No safe level of submucosal invasion
    • Glandular cancer beneath the surface lining
    • Irregular malignant glands at high power
    • Training, workload and safety of endoscopic therapy
    • Patients unsuited to esophageal preservation
    • Normal hiatus compared with a hiatal hernia
    • Vagal sparing esophagectomy
    • Removing the diseased segment and rejoining the esophagus

    14 slides

  6. 06

    Choosing the operation

    Where the tumour sits decides what is done to it

    • When resection remains the mainstay
    • Treatment chosen by tumour site
    • Cervical cancer close to the cricopharyngeus
    • Lower cervical and upper thoracic tumours
    • Bowel used to replace the esophagus
    • Mid thoracic, lower thoracic, junction and cardia tumours
    • Stomach pulled up into the chest after total esophagectomy
    • Partial esophagectomy and rejoining

    8 slides

  7. 07

    Margins in an en bloc resection

    Clear edges in three directions, and what happens when they are not

    • The three margins that must be clear
    • Proximal margin length and specimen shrinkage
    • Radial margin and survival

    3 slides

  8. 08

    Lymphadenectomy

    How many nodes to remove, and the one prognostic factor the surgeon controls

    • Node count as a survival predictor
    • Ranking of the prognostic factors
    • Esophageal cancer spread to nearby lymph nodes
    • The third field: cervical node dissection
    • Nodes found during the initial neck dissection

    5 slides

  9. 09

    En bloc versus transhiatal resection

    Which patients actually gain from the bigger operation

    • Design of the comparison
    • What the comparison showed
    • Node count and the probability of systemic disease

    3 slides

  10. 10

    Ischemia of the reconstruction conduit

    The complication the author calls the Achilles heel of esophageal resection

    • Why the conduit is the weak point
    • Factors that contribute to conduit ischemia
    • Managing a worrisome conduit at operation
    • Delayed reconstruction after an ischemic conduit
    • Results of the delayed strategy

    5 slides

  11. 11

    Chemotherapy and chemoradiation

    Two decades of trials, and why the author thinks they answered the wrong question

    • Why the trials multiplied
    • Where the evidence stands
    • The staging flaw in the current trials
    • What neoadjuvant therapy actually achieves
    • Two trial designs worth running
    • Definitive chemoradiation and the case against surgery
    • < 2%
    • Centralization of esophageal surgery

    8 slides

  12. 12

    Technique of the tri-incision esophagogastrectomy

    Where this unit's version of the McKeown operation differs in detail

    • Starting in the right chest
    • Skeletonizing the aorta
    • Azygos vein and thoracic duct
    • Scar lines left by esophageal cancer surgery
    • Chest drainage after the resection
    • Effect of that drainage plan
    • Abdominal skeletonization
    • Exposing the inferior wall of the portal vein
    • Gastric conduit and pyloroplasty

    9 slides

  13. 13

    Minimally invasive esophagectomy

    What keyhole access has delivered, and where its limit lies

    • What the minimally invasive approach has delivered
    • Keeping the extent of the dissection
    • The limit of minimal access

    3 slides

  14. 14

    Key points

    What to carry away from this perspective

    • Key points: disease and diagnosis
    • Key points: treatment decisions
    • Key points: complications and the future
    • References
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    6 slides